Results 181 to 190 of about 74,951 (264)

Somatostatin Receptor Imaging in the Diagnosis and Management of Parathyroid Neuroendocrine Neoplasia. [PDF]

Diagnostics (Basel)
Tsoy U, Pogosian K, Ryzhkova D, Yudina O, Yakovenko K, Ryazanov P, Matsueva I, Sokolnikova P, Salov M, Karonova T, Grineva E.   +10 more
europepmc   +1 more source

Insulinoma with suspected mutant somatostatin receptor expression according to histological examination. [PDF]

Clin Case Rep
Onish S, Takada-Watanabe A, Osamura RY, Shiomi T, Kusano H, Maezawa Y, Murai H, Miyabayashi M, Koike S, Yoshida T, Takemoto M.   +10 more
europepmc   +1 more source

Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells. [PDF]

Theranostics
Nguyen N, Min Y, Rivière J, van der Garde M, Ghosh S, Bartos LM, Brendel M, Bassermann F, Azhdarinia A, Weber WA, Götze KS, Kossatz S.   +11 more
europepmc   +1 more source

Distribution and calcium signaling function of somatostatin receptor subtypes in rat pituitary. [PDF]

Cell Calcium
Sivcev S, Constantin S, Smiljanic K, Sokanovic SJ, Fletcher PA, Sherman AS, Zemkova H, Stojilkovic SS.   +7 more
europepmc   +1 more source

Unveiling Hemangiopericytoma: A case demonstrating the utility of somatostatin receptor-positive metastatic hemangiopericytoma on ⁶⁸Ga-DOTA TOC PET/CT. [PDF]

Sultan Qaboos Univ Med J
Usmani S, Riyami KA, Jain A, Hashmi SF, Abubakar S, Busaidi AA.   +5 more
europepmc   +1 more source

Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal Malignancies. [PDF]

Cancers (Basel)
Xue E, Bracken-Clarke D, Krause H, Adeyelu T, Evans MG, Akbulut D, Quezado M, Gandhi N, Farrell A, Soares HP, Lou E, Phan M, Patel R, Vanderwalde AM, Elliott A, Steuer CE, Saba NF, Lubin DJ, London NR, Gulley JL, Floudas CS.   +20 more
europepmc   +1 more source

Correction to: Safety and dosimetry of [¹⁷⁷Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study. [PDF]

Eur J Nucl Med Mol Imaging
Gaze MN, Handkiewicz-Junak D, Hladun R, Laetsch TW, Sorge C, Sparks R, Wan S, Ceraulo A, Kluczewska-Galka A, Gámez-Cenzano C, States LJ, El Khouli R, Aimone P, Perraud K, Kollar G, Khanshan F, Blumenstein L, Brouri F, Giraudet AL.   +18 more
europepmc   +1 more source

GLI1-Altered Mesenchymal Tumor with ACTB Fusion and Somatostatin Receptor 2A (SSTR2A) Immunopositivity. [PDF]

Cureus
Grove J, Geisler DL, Naous R.
europepmc   +1 more source

Somatostatin Receptor 2 Negative Pheochromocytoma Masked by Normal Adrenal Gland on Gallium-68 DOTATATE. [PDF]

AACE Clin Case Rep
Park SE, Hoang TD, Stocker DJ, Shakir MKM, Spiro AJ.   +4 more
europepmc   +1 more source